ArticleFrontiers in immunology2025

Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration.

Yanelys Morera-Díaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.